TriVascular Technologies, Inc. to Present at the Canaccord Genuity 34th Annual Growth Conference

SANTA ROSA, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime™ Abdominal Stent Graft System, today announced that Christopher Chavez, President and CEO, will be presenting at the Canaccord Genuity 34th Annual Growth Conference on August 14, 2014 in Boston.

Mr. Chavez is scheduled to present at 2:30pm ET. Interested individuals can access the live audio webcast on the investor relations section of the Company's Web site at: The webcast will be available on the Company's Web site for two weeks following completion of the presentation.

About TriVascular Technologies, Inc. - TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company manufactures the Ovation Prime Abdominal Stent Graft System, the lowest profile FDA-approved endovascular aortic repair (EVAR) system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.

CONTACT: Investor Relations Contact: Michael Kramer, Chief Financial Officer +1-707.543.8709Source:TriVascular Technologies, Inc.